Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 1/20 | 0.34 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26468803 | 0.85 | CCR1 (0.36) | AVPR2AVPR1ABACE1KDM4E | |
| SCHEMBL26469950 | 0.83 | CCR1 (0.38) | AVPR2AVPR1ABACE1KDM4E | |
| SCHEMBL26468786 | 0.82 | CCR1 (0.36) | AVPR2AVPR1ABACE1KDM4E | |
| SCHEMBL26468776 | 0.78 | BACE1 (0.37) | AVPR2AVPR1ABACE1KDM4E | |
| SCHEMBL26468813 | 0.78 | CCR1 (0.33) | AVPR2AVPR1ABACE1KDM4E | |
| SCHEMBL26468802 | 0.76 | PGR (0.34) | AVPR2AVPR1ABACE1KDM4E | |
| SCHEMBL26468809 | 0.76 | CCR1 (0.33) | AVPR2AVPR1ABACE1KDM4E | |
| SCHEMBL26468596 | 0.76 | BACE1 (0.36) | AVPR2AVPR1ABACE1KDM4E | |
| SCHEMBL26468794 | 0.76 | PGR (0.36) | AVPR2AVPR1ABACE1KDM4E | |
| SCHEMBL17789429 | 0.75 | CCR1 (0.38) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230137213-A1 | NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
| US-20230137213-A1 | NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230137213-A1 | NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | PPOX, PAH, CRY2 | AVPR2 3770/4885AVPR1A 3511/4885BACE1 260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.